Skip to main content
Erschienen in: Breast Cancer Research 2/2008

01.05.2008 | Poster presentation

Investigation of immunoregulatory mechanisms relating to poor surgical wound healing and breast cancer recurrence

verfasst von: BV Hogan, HG Shenoy, MB Peter, NM Orsi, C Carter, K Horgan, TA Hughes

Erschienen in: Breast Cancer Research | Sonderheft 2/2008

Einloggen, um Zugang zu erhalten

Excerpt

The factors leading to breast cancer recurrence are incompletely understood. We recently carried out a retrospective study of treatment and outcome for 1,065 breast cancer patients for which we examined factors correlating with cancer recurrence. We found that infection of surgical wounds after surgery for primary disease positively correlated with cancer recurrence [1]. Patients with wound complications were almost threefold more likely to have systemic recurrences than those without over the follow-up period (P < 0.0001). The aim of our current study is to determine mechanisms responsible for this correlation. Our approach is based on two possible theories. First, patients may have an underlying immune dysfunction that predisposes them to developing both wound complications and also recurrence. This may be as a result of the tumour itself suppressing the activity of immune regulatory cells including dendritic cells, T cells and NK cells via increased levels of some critical cytokines (for example, vascular endothelial growth factor, IL-10, IL-6). Secondly, factors released at sites of wound complications may have direct influences on the remaining occult tumour cells, thereby increasing the likelihood of metastases. This model is supported by observations that cytokines released at sites of infection as part of inflammatory/immune responses are capable of enhancing growth and survival of tumour cells [2]. Also there is evidence that bacterial components may stimulate metastatic growth, most probably via cytokine mediators [3]. …
Literatur
1.
Zurück zum Zitat Murthy , et al: Post operative wound complications and systemic recurrence in breast cancer. Br J Cancer. 2007, 97: 1211-1217. 10.1038/sj.bjc.6604004.CrossRefPubMedPubMedCentral Murthy , et al: Post operative wound complications and systemic recurrence in breast cancer. Br J Cancer. 2007, 97: 1211-1217. 10.1038/sj.bjc.6604004.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Szlosarek P, Charles K, Balkwill F: TNF as a tumour promoter. Eur J Cancer. 2006, 42: 745-750. 10.1016/j.ejca.2006.01.012.CrossRefPubMed Szlosarek P, Charles K, Balkwill F: TNF as a tumour promoter. Eur J Cancer. 2006, 42: 745-750. 10.1016/j.ejca.2006.01.012.CrossRefPubMed
3.
Zurück zum Zitat Pidgeon G, Harmey J, Kay E, et al: The role of endotoxin/LPS in surgically induced tumour growth in a murine model of metastases. Br J Cancer. 1999, 81: 1311-1317. 10.1038/sj.bjc.6694369.CrossRefPubMedPubMedCentral Pidgeon G, Harmey J, Kay E, et al: The role of endotoxin/LPS in surgically induced tumour growth in a murine model of metastases. Br J Cancer. 1999, 81: 1311-1317. 10.1038/sj.bjc.6694369.CrossRefPubMedPubMedCentral
Metadaten
Titel
Investigation of immunoregulatory mechanisms relating to poor surgical wound healing and breast cancer recurrence
verfasst von
BV Hogan
HG Shenoy
MB Peter
NM Orsi
C Carter
K Horgan
TA Hughes
Publikationsdatum
01.05.2008
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe Sonderheft 2/2008
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1967

Weitere Artikel der Sonderheft 2/2008

Breast Cancer Research 2/2008 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.